Literature DB >> 24820664

Pemphigus vulgaris is characterized by low IgG reactivities to specific self-antigens along with high IgG reactivity to desmoglein 3.

Ittai Fattal1, Jacob Rimer, Noam Shental, Yair Molad, Armando Gabrielli, Avi Livneh, Ofer Sarig, Ilan Goldberg, Uzi Gafter, Eytan Domany, Irun R Cohen.   

Abstract

Pemphigus vulgaris (PV) is an autoimmune skin disease, which has been characterized by IgG autoantibodies to desmoglein 3. Here we studied the antibody signatures of PV patients compared with healthy subjects and with patients with two other autoimmune diseases with skin manifestations (systemic lupus erythematosus and scleroderma), using an antigen microarray and informatics analysis. We now report a previously unobserved phenomenon--patients with PV, compared with the healthy subjects and the two other diseases, show a significant decrease in IgG autoantibodies to a specific set of self-antigens. This novel finding demonstrates that an autoimmune disease may be associated with a loss of specific, healthy IgG autoantibodies and not only with a gain of specific, pathogenic IgG autoantibodies.
© 2014 John Wiley & Sons Ltd.

Entities:  

Keywords:  autoantibodies; pemphigus vulgaris; scleroderma; systemic lupus erythematosus

Mesh:

Substances:

Year:  2014        PMID: 24820664      PMCID: PMC4212951          DOI: 10.1111/imm.12316

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  27 in total

Review 1.  The HSP60 immune system network.

Authors:  Francisco J Quintana; Irun R Cohen
Journal:  Trends Immunol       Date:  2010-12-08       Impact factor: 16.687

Review 2.  Antigen-chip technology for accessing global information about the state of the body.

Authors:  F J Quintana; Y Merbl; E Sahar; E Domany; I R Cohen
Journal:  Lupus       Date:  2006       Impact factor: 2.911

Review 3.  The pathogenic role of autoantibodies in pemphigus vulgaris.

Authors:  M Pan; X Liu; J Zheng
Journal:  Clin Exp Dermatol       Date:  2011-09-09       Impact factor: 3.470

4.  Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus.

Authors:  M C Hochberg
Journal:  Arthritis Rheum       Date:  1997-09

Review 5.  Intravenous immunoglobulin therapy: how does IgG modulate the immune system?

Authors:  Inessa Schwab; Falk Nimmerjahn
Journal:  Nat Rev Immunol       Date:  2013-02-15       Impact factor: 53.106

6.  The distribution of pemphigus vulgaris-IgG subclasses and their reactivity with desmoglein 3 and 1 in pemphigus patients and their first-degree relatives.

Authors:  D Kricheli; M David; M Frusic-Zlotkin; D Goldsmith; M Rabinov; J Sulkes; Y Milner
Journal:  Br J Dermatol       Date:  2000-08       Impact factor: 9.302

7.  A comparison of anti-desmoglein antibodies and indirect immunofluorescence in the serodiagnosis of pemphigus vulgaris.

Authors:  Irena Zagorodniuk; Sara Weltfriend; Lily Shtruminger; Eli Sprecher; Olga Kogan; Shimon Pollack; Reuven Bergman
Journal:  Int J Dermatol       Date:  2005-07       Impact factor: 2.736

Review 8.  Hsp60 expression, new locations, functions and perspectives for cancer diagnosis and therapy.

Authors:  Francesco Cappello; Everly Conway de Macario; Lorenzo Marasà; Giovanni Zummo; Alberto J L Macario
Journal:  Cancer Biol Ther       Date:  2008-05-13       Impact factor: 4.742

9.  Pemphigus vulgaris antigen (desmoglein 3) is localized in the lower epidermis, the site of blister formation in patients.

Authors:  M Amagai; P J Koch; T Nishikawa; J R Stanley
Journal:  J Invest Dermatol       Date:  1996-02       Impact factor: 8.551

10.  Fabp3 inhibits proliferation and promotes apoptosis of embryonic myocardial cells.

Authors:  C Zhu; D L Hu; Y Q Liu; Q J Zhang; F K Chen; X Q Kong; K J Cao; J S Zhang; L M Qian
Journal:  Cell Biochem Biophys       Date:  2011-07       Impact factor: 2.194

View more
  1 in total

1.  Comparative study for haplotype block partitioning methods - Evidence from chromosome 6 of the North American Rheumatoid Arthritis Consortium (NARAC) dataset.

Authors:  Mohamed N Saad; Mai S Mabrouk; Ayman M Eldeib; Olfat G Shaker
Journal:  PLoS One       Date:  2018-12-31       Impact factor: 3.240

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.